Welch Group’s Idexx Laboratories IDXX Stock Holding History

Welch Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,000	Closed	-$154	–	149
2015 Q1	$154	Hold	2,000	–	–	0.03%	124
2014 Q4	$148K	Hold	2,000	–	–	0.03%	123
2014 Q3	$118K	Hold	2,000	–	–	0.02%	133
2014 Q2	$134K	Hold	2,000	–	–	0.03%	127
2014 Q1	$121K	Buy	+2,000	New	+$119K	0.03%	118

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Welch Group's IDXX Position: Q2 2015 in Review

Welch Group sold out of Idexx Laboratories (IDXX) in Q2 2015, closing a stake of 2,000 shares — an estimated $154 sold.

Welch Group first reported a position in IDXX in Q1 2014 and held it in 5 quarters. The position peaked at $148K in Q4 2014. 348 funds tracked by Wall St. Rank hold IDXX as of Q2 2015.

Welch Group reported no remaining Idexx Laboratories position as of Q2 2015 after selling out during the quarter.
Welch Group sold 2,000 Idexx Laboratories shares in Q2 2015, an estimated $154.
Welch Group first reported a position in Idexx Laboratories in Q1 2014 and held it in 5 quarters.
Welch Group's Idexx Laboratories position peaked at $148K in Q4 2014.
348 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2015.

Based on Welch Group's 13F filing for Q2 2015, filed 31 Jul 2015.